[1]Hilleman MR.Overview of the pathogenesis, prophylaxis and thera-peusis of viral hepatitis B, with focus on reduction to practical appli-cations[J].Vaccine, 2001, 19∶1837-1848.
|
[2]梁晓峰, 陈园生, 王晓军, 等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005, 26∶655-658.
|
[3]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2001, 34∶1225-1241.
|
[4]Banchereau J, Steinman RM.Dendritic cells and the control of im-munity[J].Nature, 1998, 392∶245-52.
|
[5]Robinson SP, Patterson S, English N, et al.Human peripheralblood contains two distinct lineages of dendritic cells[J].Eur J Im-munol, 1999, 29∶2769-78.
|
[6]Wang FS, Xing LH, Liu MX, et al.Dysfunction of peripheral blooddendritic cells from patients with chronic hepatitis B virusinfection[J].World J Gastroenterol, 2001, 7∶537-41.
|
[7]Arima S, Akbar SM, Michitaka K, et al.Impaired function of anti-gen-presenting dendritic cells in patients with chronic hepatitis B:localization of HBV DNA and HBV RNA in blood DC by in situ hy-bridization[J].Int J Mol Med, 2003, 11∶169-74.
|
[8]Beckebaum S, Cicinnati VR, Dworacki G, et al.Reduction in thecirculating pDC1/pDC2 ratio and impaired function of exvivogenerat-ed DC1 in chronic hepatitis B infection[J].Clin Immunol, 2002, 104∶138-50.
|
[9]Van derMolen RG, Sprengers D, Binda RS, et al.Functional im-pairment of myeloid and plasmacytoid dendritic cells of patients withchronic hepatitis B[J].Hepatology, 2004, 40∶738-46.
|
[10]Gabrilovich DI, Patterson S, Harvey JJ, et al.Defects in the functionof dendrentic cells in murine retroviral infection[J].Adv Exp MedBiol, 1995, 378∶469-472.
|
[11] 中华医学会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19:56-62.
|
[12]Paul S, Kyung DP, Melissa R, et al.Absolute values of dendriticcell subsets in bone marrow, cord blood, and peripheral blood enu-merated by a novel method[J].Stem Cells, 2003, 21∶2962303.
|
[13]Van der Molen RG, Spreagers D, Birda RS, et al.Functional im-pairmentin of myeloid and plasmacytiod dendritic cells of patientswith chronic hepatitis B[J].Hepatology, 2004, 40 (3) ∶738-746.
|
[14]李若冰, 陈红松, 费然, 等.慢性乙型肝炎病人外周血树突细胞功能的研究[J].中华医学杂志, 2002, 82 (13) :887-890.
|
[15]Kunitani H, Shimizu Y, Murata H, et al.Phenotypic analysis ofcirculating and intrahepatic dendritic cell subsets in patients withchronic liver diseases[J].J Hepatal, 2002, 36∶734-741.
|
[16]Tavakoli S, Mederacke I, Herzog-Hauff S, et al.Peripheral blooddendritic cells are phenotypically and functionally intact in chronichepatitis B virus (HBV) infection[J].Clinical and Experim-entalImmunology, 2007, 151∶60-70.
|
[17]Beckebaum S, Cicinnati VR, Dworacki G, et al.Reduction in thecirculating MDC/PDC ratio and impaired function of exvivor-gener-ated DC1 in chronic hepatitis B infection[J].Clinical Immunology, 2002, 104∶138-150.
|
[18]Liu YJ.Dendritic cells subsets and lineagesand their functions in in-nate and adaptive[J].immunity Cell, 2001, 106∶259-262.
|
[19]Munz C, Steinman RM, Fujii S.Dendritic cell maturation by innatelymphocytes∶coordinated stimulation of innate and adaptiveimmunity[J].J Exp Med, 2005, 202∶203-207.
|
[20]骆抗先.乙型肝炎基础和临床[M].2版.北京:人民卫生出版社, 2001∶35.
|
[1] | Yao ZHANG, Kai ZHANG, Chao MA. Clinical significance of FAT4 protein expression in pancreatic cancer[J]. Journal of Clinical Hepatology, 2022, 38(12): 2802-2806. doi: 10.3969/j.issn.1001-5256.2022.12.021 |
[2] | ZHOU Ge, XIE LiPing, LIN TaoFa, LU YouGuang, WANG ShaoYang. Expression and significance of programmed death-1 and T-cell immunoglobulin-and mucin domain-3-containing molecule 3 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(11): 2450-2455. doi: 10.3969/j.issn.1001-5256.2020.11.011 |
[3] | Ye LiHong, Zheng HuanWei, Huang XiaoYu, Guo LiJie, Zhang HaiCong, Liu ZhiQuan, Wang ChongKui. Expression characteristics and significance of three transmembrane transport proteins in liver tissue in bile duct injury type of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(7): 1562-1566. doi: 10.3969/j.issn.1001-5256.2020.07.022 |
[4] | Ceng ChaiMing, Yan MaoLin, Shi YiHai, Guo TaiLin, Mei AiNong, Chen JianKang, Xu GuiPing, He XiaoHong. Changes in the expression of 17-β-hydroxysteroid dehydrogenase 13 and mitofusin 2 in liver cancer tissue and a bioinformatics analysis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2736-2740. doi: 10.3969/j.issn.1001-5256.2019.12.019 |
[5] | Fan Bin, Zhang Yong, Li JinMao, Liu Tao, Zhang JiaYao. Association between the expression of centromere protein F and prognosis in patients with hepatocellular carcinoma:An analysis using GEO database[J]. Journal of Clinical Hepatology, 2018, 34(7): 1475-1480. doi: 10.3969/j.issn.1001-5256.2018.07.022 |
[6] | Xu QingNian, Lu YunFei, Tang BoZong, Chen XiaoRong, Yang ZongGuo. Correlation between mRNA expression of heat shock protein in tumor tissue and tumor stage in patients with HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(5): 869-874. doi: 10.3969/j.issn.1001-5256.2017.05.015 |
[7] | Wang JianGang, Fei XinYing, Song Qing. Application of proteomics in study of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 958-960. doi: 10.3969/j.issn.1001-5256.2014.09.030 |
[8] | Guo XiaoDong, Li ZhiWei, Yang Mei, Xiong Lu. Expression of Caspase-9 and Survivin in hepatocellular carcinoma tissues and its clinical significance[J]. Journal of Clinical Hepatology, 2014, 30(3): 253-256. doi: 10.3969/j.issn.1001-5256.2014.03.014 |
[9] | Qiu Shi, Dong WeiGuo, Yang ZiRong, Zhang JiXiang. Differential expression of liver-intestine cadherin in hepatocellular carcinoma and its clinical significance[J]. Journal of Clinical Hepatology, 2013, 29(1): 62-64. |
[10] | Wang YingChun, Liu YanFang, Zhu RuiPing, Song XinXin, Li XiaoHuan. Expression of histone deacetylase 1 and matrix metalloproteinase-2 in hepatocellular carcinoma and its significance[J]. Journal of Clinical Hepatology, 2012, 28(4): 276-278+288. |
[11] | Li HongTao, Xu LiYu, Gan HongJun, Zhang YuanYuan, Liu Yong, Lu MingZhi. The expression and significance of p16 and cyclin D1 in gallbladder carcinoma[J]. Journal of Clinical Hepatology, 2010, 26(2): 199-202. |
[12] | Yang HuanXing, Yang YingHong, Lin MingXi, Huang JianPing. Relationship Between M30 Expression and Apoptosis in Primary Hepatic Carcinoma[J]. Journal of Clinical Hepatology, 2009, 25(1): 20-22. |
[13] | Zhang RongGui, Tang ZhengHao, Feng Jie, Zang GuoQing, Yu YongSheng. The expression of c-myb in HCC tissues and clinical significance.[J]. Journal of Clinical Hepatology, 2008, 24(2): 106-108. |
[14] | Zhang MingWei, Zhang Jing, Zhao ZhengHong. Dentritic cell infiltration and PCNA expression in gallbladder carcinoma and their significances.[J]. Journal of Clinical Hepatology, 2002, 18(5): 288-289. |
[15] | Gu HuaPing, Shang PeiZhong, Zhou CuiLing. Expression of CD15 and Bcl-2 in gallbladder carcinoma and their relationship[J]. Journal of Clinical Hepatology, 2001, 17(1): 57-58. |